[1] Schafer K,Goldschmidt E,Oostra D,et al.Wells Clinical Probability and D-dimer Testing: Risk Stratification for Acute Lower Extremity Deep Vein Thrombosis[J].Journal of vascular surgery,2021,10(5):1021-1027.
[2] 陈博,杜岩.阿司匹林联合氯吡格雷治疗急性脑梗死临床效果观察[J].临床军医杂志,2021,49(3):352-353.
[3] 张芮娟. 依达拉奉+阿托伐他汀钙治疗脑梗死的效果及对患者神经功能的影响[J].贵州医药, 2021, 45(011):1728-1729.
[4] 周晓亚,陈国芳,张文丽,等.前蛋白转化酶枯草溶菌素9抑制剂联合瑞舒伐他汀对急性缺血性脑卒中患者血脂水平和短期预后的影响[J].中华神经科杂志, 2024, 57(6):625-633.
[5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[6] Fluck D,Fry CH,Gulli G,et al.Association of risk of malnutrition with adverse outcomes and early support on discharge in acute stroke patients without prestroke disability: A multicenter, registry-based cohort study[J].Nutr Clin Pract,2022,37(5):1233-1241.
[7] Cui,BinYang DandanZheng, WeiminWu,YeYang,QiWang, ZhiqunZhao,Xihai.Plaque enhancement in multi-cerebrovascular beds associates with acute cerebral infarction[J].Acta Radiologica,2021,62(1):102-112.
[8] 马大伟,李伟,李春燕.复方脑肽节苷脂注射液联合替罗非班治疗急性脑梗死的临床研究[J].现代药物与临床,2022,37(7):1497-1501.
[9] 朱学芳,朱建建,韩鲜艳.替罗非班桥接拜阿司匹林和氯吡格雷双抗对超时间窗急性脑梗死患者血小板活化的影响研究[J].哈尔滨医科大学学报,2022,56(4):363-367.
[10] 马利菊,杜平,孙许锋,等.复方丹参滴丸联合阿托伐他汀对急性脑梗死患者颈动脉粥样硬化斑块稳定性超声参数及血清LDL-C和D-D的影响[J].现代中西医结合杂志,2022,31(15):2104-2107,2145.
[11] 文洪波,黄健康,姚义琴,等.阿托伐他汀钙与匹伐他汀钙对急性脑梗死合并颈动脉粥样硬化斑块患者颈动脉斑块和血脂的影响[J].海南医学,2021,32(12):1541-1544.
[12] 胡群亮,田竺,张盛蕊,等.PCSK9抑制剂联合阿托伐他汀对颅内动脉粥样硬化性狭窄的治疗效果[J].中风与神经疾病杂志, 2024, 41(4):349-354. |
